EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The CD40/CD40 ligand dyad and its downstream effector molecule ISG54 in relating acute neuroinflammation with persistent, progressive demyelination

Bishal Hazra, Jayasri Das Sarma iD

IUBMB Life · 2024

DOI: 10.1002/iub.2798 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift IUBMB Life, 2024. Verfasst von Bishal Hazra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, India. Hauptthemen laut MEDLINE: CD40 Ligand, Neuroinflammatory Diseases, Demyelinating Diseases, CD40 Antigens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although Multiple Sclerosis (MS) is primarily thought to be an autoimmune condition, its possible viral etiology must be taken into consideration. When mice are administered neurotropic viruses like mouse hepatitis virus MHV‐A59, a murine coronavirus, or its isogenic recombinant strain RSA59, neuroinflammation along with demyelination are observed, which are some of the significant manifestations of MS. MHV‐A59/RSA59 induced neuroinflammation is one of the best‐studied experimental animal models to understand the viral‐induced demyelination concurrent with axonal loss. In this experimental animal model, one of the major immune checkpoint regulators is the CD40‐CD40L dyad, which helps in mediating both acute‐innate, innate‐adaptive, and chronic‐adaptive immune responses. Hence, they are essential in reducing acute neuroinflammation and chronic progressive adaptive demyelination. While CD40 is expressed on antigen‐presenting cells and endothelial cells, CD40L is expressed primarily on activated T cells and during severe inflammation on NK cells and mast cells. Experimental evidences revealed that genetic deficiency of both these proteins can lead to deleterious effects in an individual. On the other hand, interferon‐stimulated genes (ISGs) possess potent antiviral properties and directly or indirectly alter acute neuroinflammation. In this review, we will discuss the role of an ISG, ISG54, and its tetratricopeptide repeat protein Ifit2; the genetic and experimental studies on the role of CD40 and CD40L in a virus‐induced neuroinflammatory demyelination model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD40 LigandNeuroinflammatory DiseasesDemyelinating DiseasesCD40 AntigensMurine hepatitis virusAnimalsHumansMiceMultiple SclerosisDisease Models, Animal

Stichwörter der Autor:innen

CD40‐CD40L dyadIfit2MHV‐A59/RSA59MSdemyelinationinnate and adaptive immune responsesinterferon‐stimulated genes

Substanzen

CD40 LigandCD40 Antigens

Autor:innen und Institutionen

  • Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, India.
  • Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Jayasri Das Sarma

Zitieren

APA

Hazra, B., & Das Sarma, J. (2024). The CD40/CD40 ligand dyad and its downstream effector molecule ISG54 in relating acute neuroinflammation with persistent, progressive demyelination. IUBMB Life. https://doi.org/10.1002/iub.2798

Vancouver

Hazra B, Das Sarma J. The CD40/CD40 ligand dyad and its downstream effector molecule ISG54 in relating acute neuroinflammation with persistent, progressive demyelination. IUBMB Life. 2024. doi:10.1002/iub.2798

BibTeX
@article{Hazra2024,
  author = {Hazra, Bishal and Das Sarma, Jayasri},
  title = {The CD40/CD40 ligand dyad and its downstream effector molecule ISG54 in relating acute neuroinflammation with persistent, progressive demyelination},
  journal = {IUBMB Life},
  year = {2024},
  doi = {10.1002/iub.2798}
}
Kostenlos starten →